Ever since the outbreak of the COVID-19 pandemic, hospitals have increasingly had to focus almost exclusively on meeting the challenges of the viral infection and consequently have had to put on hold investments for capital equipment in fields not directly related to the emergency.

This has created difficult market conditions for companies selling products into the diagnostic imaging business.

Despite the current tough market situation, the Italian company Esaote has posted better than expected sales revenues. We wanted to find out more about Esaote’s success in bucking the current market trend so we spoke to Franco Fontana, CEO of the Esaote Group.